Abstract
OBJECTIVE To provide a rational approach for suggesting durations of contraceptive cover for various miltefosine regimens. Use of miltefosine in the treatment of visceral leishmaniasis (vl) is hampered by its potential teratogenicity. The duration of adequate contraceptive cover in females of child-bearing potential after cessation of a potentially teratogenic drug
... read more